BioClin has been acquired by Trimb Healthcare

Orange Pearl International has sold BioClin, a leading healthcare products company, to Trimb Healthcare AB, a Swedish pharmaceutical company.

Based in the Netherlands, BioClin sells products to provide direct treatment and relief for women’s intimate health discomforts. The company’s product portfolio consists of Multi-Gyn, a complete range for treating intimate discomforts and Multi-Mam, a product range of self-care products for mothers and babies. BioClin’s brands are growing rapidly and are sold in pharmacies and drugstores in over 60 countries worldwide.

Trimb Healthcare is rapidly growing pharmaceutical company with a focus on sales, marketing and development of prescription-free OTC pharmaceuticals and consumer healthcare products.

Oaklins' team in the Netherlands acted as the exclusive sell-side advisor to the shareholders of BioClin in this transaction.

Dienst

Fusies & overnames (sell-side)

Partijen

Neem contact op met het dealteam

Robert Boersma

Partner

Amsterdam, Nederland
Oaklins Netherlands

Bekijk profiel Contact

Casper Oude Essink

Director

Amsterdam, Nederland
Oaklins Netherlands

Bekijk profiel Contact

Gerelateerde deals

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Private Equity | Energie

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.

Lees verder

Cerbios-Pharma has been acquired by HAS Healthcare

Gezondheidszorg

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Lees verder

iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets

Private Equity | Bouw & Techniek | Energie | TMT

iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets

iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.

Lees verder